Human Epidermal Growth Factor Receptor 2 (HER2/neu)

This version of the course is no longer available.
Need multiple seats for your university or lab? Get a quote
The page below is a sample from the LabCE course Tumor Markers (retired 12/7/2020). Access the complete course and earn ASCLS P.A.C.E.-approved continuing education credits by subscribing online.

Learn more about Tumor Markers (retired 12/7/2020) (online CE course)
Human Epidermal Growth Factor Receptor 2 (HER2/neu)

HER2/neu is found amplified in breast, ovarian, and tumors of the gastrointestinal tract. Increased amplification of the HER2/neu gene correlates with decreased response to hormonal therapy in breast cancer. HER2/neu has strong prognostic value in breast cancer, and correlates with increased tumor size, positivity in adjacent lymph nodes, and higher grading scores with likelihood of metastases.
HER2/neu analysis may be performed on suspicious or representative tissue samples using immunohistochemical (IHC) techniques. HER2/neu is also released into the blood, and as such, may be identified and quantified in plasma samples using commercially available immunoassay methods.2